| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.018 | 0.8 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.8 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.8 |